# Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors

> **NCT00485719** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 83 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** XL765 (SAR245409)

## Key facts

- **NCT ID:** NCT00485719
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2013-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00485719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00485719, "Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00485719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*